Clinical phenotypes of chronic obstructive pulmonary disease and asthma: Recent advances

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 3, 2013, Pages 627-634

  Carolan, Brendan J ^a,b   Sutherland, E Rand ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; biopsy; cluster analysis

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; BRONCHODILATING AGENT; C REACTIVE PROTEIN; CLARA CELL PROTEIN; CORTICOSTEROID; FIBRINOGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROLIDE; MYCOPHENOLIC ACID; OMALIZUMAB; PROTON PUMP INHIBITOR; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY OBSTRUCTION; ASTHMA; BACTERIAL INFECTION; BODY MASS; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DYSPNEA; EOSINOPHILIA; EXERCISE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG BIOPSY; LUNG EMPHYSEMA; MORTALITY; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PHENOTYPE; PHYSIOLOGICAL PROCESS; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT EXAMINATION; RESPIRATORY TRACT INFLAMMATION; REVIEW; TH2 CELL; THORAX RADIOGRAPHY; VIDEO ASSISTED THORACOSCOPIC SURGERY; VIRUS INFECTION;

ASTHMA; CLUSTER ANALYSIS; HUMANS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84875229819     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.01.010     Document Type: Review

References (46)

1. Global strategy for asthma management and prevention. December 2012 update. Available at: www.ginasthma.org/guidelines-gina-report-global-strategy- for-asthma.html. Accessed January 7, 2013.
2. J. Vestbo, S.S. Hurd, A.G. Agusti, P.W. Jones, C. Vogelmeier, and A. Anzueto Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary Am J Respir Crit Care Med 2012 [Epub ahead of print]
3. A. Agusti, P. Sobradillo, and B. Celli Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine Am J Respir Crit Care Med 183 2011 1129 1137
4. D.G. Parr Patient phenotyping and early disease detection in chronic obstructive pulmonary disease Proc Am Thorac Soc 8 2011 338 349
5. A.C. Dornhorst Respiratory insufficiency Lancet 268 1955 1185 1187
6. B.S. Everitt, S. Landau, M. Leese, and D. Stahl Cluster Analysis 2011 Wiley Hoboken (NJ)
7. P.R. Burgel, J.L. Paillasseur, D. Caillaud, I. Tillie-Leblond, P. Chanez, and R. Escamilla Clinical COPD phenotypes: a novel approach using principal component and cluster analyses Eur Respir J 36 2010 531 539
8. P.R. Burgel, N. Roche, J.L. Paillasseur, I. Tillie-Leblond, P. Chanez, and R. Escamilla Clinical COPD phenotypes identified by cluster analysis: validation with mortality Eur Respir J 40 2012 495 496
9. B.R. Celli, C.G. Cote, J.M. Marin, C. Casanova, M. Montes de Oca, and R.A. Mendez The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012
10. F.J. Martinez, M.K. Han, A.C. Andrei, R. Wise, S. Murray, and J.L. Curtis Longitudinal change in the BODE index predicts mortality in severe emphysema Am J Respir Crit Care Med 178 2008 491 499
11. K.C. Ong, A. Earnest, and S.J. Lu A multidimensional grading system (BODE index) as predictor of hospitalization for COPD Chest 128 2005 3810 3816
12. C.G. Cote, and B.R. Celli Pulmonary rehabilitation and the BODE index in COPD Eur Respir J 26 2005 630 636
13. G.C. Donaldson, T.A. Seemungal, A. Bhowmik, and J.A. Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 2002 847 852
14. R.E. Kanner, N.R. Anthonisen, and J.E. Connett Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study Am J Respir Crit Care Med 164 2001 358 364
15. T.A. Seemungal, G.C. Donaldson, A. Bhowmik, D.J. Jeffries, and J.A. Wedzicha Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 2000 1608 1613
16. J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Mullerova, and R. Tal-Singer Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 2010 1128 1138
17. M. Bafadhel, S. McKenna, S. Terry, V. Mistry, C. Reid, and P. Haldar Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers Am J Respir Crit Care Med 184 2011 662 671
18. J. Garcia-Aymerich, F.P. Gomez, M. Benet, E. Farrero, X. Basagana, and A. Gayete Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes Thorax 66 2011 430 437
19. E.A. Regan, J.E. Hokanson, J.R. Murphy, B. Make, D.A. Lynch, and T.H. Beaty Genetic epidemiology of COPD (COPDGene) study design COPD 7 2010 32 43
20. M.K. Han, E.A. Kazerooni, D.A. Lynch, L.X. Liu, S. Murray, and J.L. Curtis Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes Radiology 261 2011 274 282
21. J.M. Wells, G.R. Washko, M.K. Han, N. Abbas, H. Nath, and A.J. Mamary Pulmonary arterial enlargement and acute exacerbations of COPD N Engl J Med 367 2012 913 921
22. G.C. Donaldson, J.R. Hurst, C.J. Smith, R.B. Hubbard, and J.A. Wedzicha Increased risk of myocardial infarction and stroke following exacerbation of COPD Chest 137 2010 1091 1097
23. D.M.G. Halpin, M. Decramer, B. Celli, S. Kesten, I. Leimer, and D.P. Tashkin Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trial Lung 189 2011 261 268
24. C.H. Martinez, Y.-H. Chen, P.M. Westgate, L.X. Liu, S. Murray, and J.L. Curtis Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease Thorax 67 2012 399 406
25. R.G. Barr, D.A. Bluemke, F.S. Ahmed, J.J. Carr, P.L. Enright, and E.A. Hoffman Percent emphysema, airflow obstruction, and impaired left ventricular filling N Engl J Med 362 2010 217 227
26. C. Fletcher, and R. Peto The natural history of chronic airflow obstruction BMJ 1 1977 1645 1648
27. M. Nishimura, H. Makita, K. Nagai, S. Konno, Y. Nasuhara, and M. Hasegawa Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease Am J Respir Crit Care Med 185 2012 44 52
28. J. Vestbo, L.D. Edwards, P.D. Scanlon, J.C. Yates, A. Agusti, and P. Bakke Changes in forced expiratory volume in 1 second over time in COPD N Engl J Med 365 2011 1184 1192
29. P.M. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, and P.W. Jones Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
30. B.R. Celli, N.E. Thomas, J.A. Anderson, G.T. Ferguson, C.R. Jenkins, and P.W. Jones Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease results from the TORCH Study Am J Respir Crit Care Med 178 2008 332 338
31. S.E. Wenzel Asthma: defining of the persistent adult phenotypes Lancet 368 2006 804 813
32. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721
33. L.G. Wood, K.J. Baines, J. Fu, H.A. Scott, and P.G. Gibson The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma Chest 142 2012 86 93
34. K.W. McGrath, N. Icitovic, H.A. Boushey, S.C. Lazarus, E.R. Sutherland, and V.M. Chinchilli A large subgroup of mild-to-moderate asthma is persistently noneosinophilic Am J Respir Crit Care Med 185 2012 612 619
35. J.T. Good, C.A. Kolakowski, S.D. Groshong, J.R. Murphy, and R.J. Martin Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy Chest 141 2012 599 606
36. S.E. Wenzel, C.A. Vitari, M. Shende, D.C. Strollo, A. Larkin, and S.A. Yousem Asthmatic granulomatosis: a novel disease with asthmatic and granulomatous features Am J Respir Crit Care Med 186 2012 501 507
37. P.G. Woodruff, H.A. Boushey, G.M. Dolganov, C.S. Barker, Y.H. Yang, and S. Donnelly Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids Proc Natl Acad Sci U S A 104 2007 15858 15863
38. P. Haldar, I.D. Pavord, D.E. Shaw, M.A. Berry, M. Thomas, and C.E. Brightling Cluster analysis and clinical asthma phenotypes Am J Respir Crit Care Med 178 2008 218 224
39. W.C. Moore, D.A. Meyers, S.E. Wenzel, W.G. Teague, H. Li, and X. Li Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program Am J Respir Crit Care Med 181 2009 315 323
40. A.M. Fitzpatrick, W.G. Teague, D.A. Meyers, S.P. Peters, X. Li, and H. Li Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program J Allergy Clin Immunol 127 2011 382 389
41. R.A. Covar, J.D. Spahn, J.R. Murphy, and S.J. Szefler Progression of asthma measured by lung function in the childhood asthma management program Am J Respir Crit Care Med 170 2004 234 241
42. T.R. Bai, J.M. Vonk, D.S. Postma, and H.M. Boezen Severe exacerbations predict excess lung function decline in asthma Eur Respir J 30 2007 452 456
43. A.C. Wu, K. Tantisira, L. Li, B. Schuemann, S.T. Weiss, and A.L. Fuhlbrigge Predictors of symptoms are different from predictors of severe exacerbations from asthma in children Chest 140 2011 100 107
44. P.G. Gibson, and J.L. Simpson The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 64 2009 728 735
45. J.J. Soler-Cataluna, B. Cosio, J.L. Izquierdo, J.L. Lopez-Campos, J.M. Marin, and R. Aguero Consensus document on the overlap phenotype COPD-asthma in COPD Arch Bronconeumol 48 2012 331 337
46. M. Hardin, E.K. Silverman, R.G. Barr, N.N. Hansel, J.D. Schroeder, and B.J. Make The clinical features of the overlap between COPD and asthma Respir Res 12 2011 127